Whitney Ijem

Stock Analyst at Canaccord Genuity

(0.79)
# 2154
Out of 5,329 analysts
104
Total ratings
35.94%
Success rate
-6.03%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
RGLS Regulus Therapeutics
Downgrades: Hold
28 11
7.85 40.13% 6 Apr 30, 2025
VERV Verve Therapeutics
Maintains: Strong Buy
32 39
5.5 609.09% 5 Apr 15, 2025
RYTM Rhythm Pharmaceutica...
Maintains: Strong Buy
81 92
63.8 44.2% 7 Apr 8, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
385 390
255.12 52.87% 8 Mar 21, 2025
GBIO Generation Bio
Maintains: Buy
9 9
0.44 1945.45% 2 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 6
0.5 1100% 6 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
74 68
12.54 442.26% 5 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
39 36
7.88 356.85% 6 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
39 39
24.03 62.3% 2 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
121 136
38.96 249.08% 8 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Hold
408 424
498.44 -14.93% 8 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 90
8.66 939.26% 5 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 8
2.42 230.58% 8 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 13
0.35 3614.29% 6 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
148 150
62.8 138.85% 3 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
93 84
62.7 33.97% 8 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 30
n/a n/a 2 Jul 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
260
n/a n/a 1 Feb 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
120 240
6.78 3439.82% 4 Jul 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
33 0
n/a n/a 2 Feb 26, 2018